GlassScriptPhysician profile
Joseph Riney
NPI 1982022695
$9,904.33
in general payments reported to CMS, 2019-2025
42 companies · $2,190 in 2025
The $2,190 reported for 2025 was more than what 82% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,431 · 2020: $183 · 2021: $681 · 2022: $1,353 · 2023: $1,319 · 2024: $2,748 · 2025: $2,190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,001 · Travel and Lodging: $1,078 · Education: $178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,000.90 |
| Travel and Lodging | $1,077.61 |
| Education | $177.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,485.71 | 2022-2024 | Axonics, Bulkamid |
| Janssen Biotech, INC. | $990.52 | 2021-2025 | Erleada, Carvykti, Rybrevant |
| Astellas Pharma US INC | $988.31 | 2019-2025 | Xtandi, Myrbetriq |
| Medtronic USA, INC. | $964.69 | 2019 | |
| Boston Scientific Corporation | $661.26 | 2019-2025 | General - Therapies, Tria Firm, Ams 700 |
| Pfizer INC. | $655.29 | 2021-2025 | |
| Abbvie INC. | $431.68 | 2019-2025 | Lupron Depot, Botox |
| Sumitomo Pharma America, INC. | $375.48 | 2023-2025 | Gemtesa, Orgovyx |
| 180 Medical, INC. | $338.06 | 2021-2025 | |
| Endo USA, INC. | $254.06 | 2024-2025 | Xiaflex, Aveed |
| Endo Pharmaceuticals INC. | $242.58 | 2020-2024 | Xiaflex, Aveed |
| Procept Biorobotics Corporation | $213.46 | 2019-2025 | Aquabeam Robotic System, Aquabeam System |
| Novartis Pharmaceuticals Corporation | $204.72 | 2022-2025 | |
| Urogen Pharma, INC. | $178.43 | 2023-2025 | Jelmyto |
| Tolmar, INC. | $170.23 | 2023-2025 | Eligard, Jatenzo |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $165.13 | 2021-2024 | Urolift |
| Olympus America INC. | $160.30 | 2019-2025 | Evis Exera III Video System Center, Soltive, Itind System |
| C. R. Bard, INC. & Subsidiaries | $153.94 | 2024-2025 | Bard Urinary Drainage Bag |
| Immunitybio, INC. | $144.00 | 2024-2025 | |
| Progenics Pharmaceuticals, INC. | $143.56 | 2023-2025 | Pylarify |
| Urovant Sciences INC | $118.90 | 2022 | |
| Dendreon Pharmaceuticals LLC | $91.27 | 2024-2025 | Provenge |
| Abiomed | $79.44 | 2024 | Impella |
| Ethicon US, LLC | $75.34 | 2023-2024 | Stratafix, Monocryl, Dermabond |
| Medtronic, INC. | $74.68 | 2023-2024 | Interstim, Ligasure |
| Sun Pharmaceutical Industries INC. | $69.99 | 2022-2023 | Yonsa |
| Blue Earth Diagnostics | $68.99 | 2023-2025 | Posluma |
| Ferring Pharmaceuticals INC. | $61.99 | 2025 | Adstiladrin |
| Karl Storz Endoscopy-America | $56.12 | 2023 | Hopkins |
| Calyxo, INC. | $49.49 | 2024-2025 | Cvac Aspiration System |
| Coloplast Corp | $37.43 | 2021-2024 | |
| Bioprotect Medical, INC. | $31.74 | 2025 | Bioprotect Balloon Implant System |
| Tolmar Pharmaceuticals, INC. | $21.98 | 2022 | |
| Neotract INC. | $20.09 | 2020 | |
| Myovant Sciences INC. | $18.20 | 2022 | |
| Merck Sharp & Dohme LLC | $17.50 | 2024 | Keytruda, Welireg |
| Palette Life Sciences, INC. | $17.07 | 2022 | |
| Myriad Genetic Laboratories, INC. | $15.97 | 2025 | Prolaris |
| Bayer Healthcare Pharmaceuticals INC. | $15.86 | 2024 | |
| Sagent Pharmaceuticals | $14.64 | 2022 | |
| Laborie Medical Technologies Corp. | $13.51 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $12.72 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Riney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.